Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Resverlogix Corp.    RVX   CA76128M1086

RESVERLOGIX CORP. (RVX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Resverlogix : IIROC Trade Resumption - Resverlogix Corp.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/13/2017 | 03:33pm CEST

Toronto, Ontario--(Newsfile Corp. - October 13, 2017) - Trading resumes in:

Company:

Resverlogix Corp.

TSX Symbol:

RVX (all issues)

Resumption Time (ET):

10:00

 

 

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

- 30 -

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) - Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

© Newsfile Corp, source Press Releases

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RESVERLOGIX CORP.
06/19RESVERLOGIX : Announces fda confirmation regarding filing pathway for apabetalon..
AQ
06/14RESVERLOGIX : Data from Resverlogix Advance Knowledge in Kidney Disease (Benefit..
AQ
06/14RESVERLOGIX : Announces FDA Confirmation Regarding Filing Pathway for Apabetalon..
GL
06/14RESVERLOGIX : Announces FDA Confirmation Regarding Filing Pathway for Apabetalon..
AQ
06/13RESVERLOGIX : Announces withdrawal of public offering of units
AQ
06/12RESVERLOGIX : Highlights potential to develop apabetalone as a therapeutic for h..
AQ
06/09RESVERLOGIX : Announces Withdrawal of Public Offering of Units
AQ
06/08RESVERLOGIX : Highlights Potential to Develop Apabetalone as a Therapeutic for H..
AQ
06/07Resverlogix Highlights Potential to Develop Apabetalone as a Therapeutic for ..
GL
06/07RESVERLOGIX : Highlights Potential to Develop Apabetalone as a Therapeutic for H..
GL
More news
News from SeekingAlpha
06/16YOUR DAILY PHARMA SCOOP : Resverlogix Cleared For Trial, ViiV Positive Data, Eli.. 
06/14FDA on board with Resverlogix BETonMACE study 
05/03Resverlogix (RVXCF) Presents At 2018 Bloom Burton & Co. Healthcare Investor C.. 
04/12TSX extends review of Resverlogix's compliance with listing requirements 
04/11Resverlogix announces US$30M loan commitment letter 
Chart RESVERLOGIX CORP.
Duration : Period :
Resverlogix Corp. Technical Analysis Chart | RVX | CA76128M1086 | 4-Traders
Technical analysis trends RESVERLOGIX CORP.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 8,55  CAD
Spread / Average Target 259%
Managers
NameTitle
Donald J. McCaffrey Chairman, President, CEO & Secretary
Anthony Brad Cann Chief Financial Officer
Norman C. W. Wong Chief Scientific Officer
Jan O. Johansson Senior Vice President-Medical Affairs
Michael T. Sweeney Senior Vice President-Clinical Development
Sector and Competitors
1st jan.Capitalization (M$)
RESVERLOGIX CORP.16.10%326
CELLTRION, INC.--.--%34 574
IQVIA HOLDINGS INC8.22%21 638
LONZA GROUP1.10%20 183
INCYTE CORPORATION-23.96%15 266
ALNYLAM PHARMACEUTICALS, INC.-17.65%10 678